SURROGATE ENDPOINTS IN ONCOLOGY: A REVIEW OF RECENT HEALTH TECHNOLOGY APPRAISALS IN THE UNITED KINGDOM

被引：0
|
作者：
Wissinger, E. [1 ]
Koufopoulou, M. [2 ]
Fusco, N. [1 ]
Stewart, F. [3 ]
Oladapo, T. [2 ]
Depalma, S. [3 ]
Devani, D. [1 ]
Rangi, N. D. [2 ]
机构：
[1] AmerisourceBergen, Carrollton, TX USA
[2] AmerisourceBergen, London, England
[3] AmerisourceBergen, Hannover, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA41
引用
收藏
页码：S265 / S266
页数：2
相关论文
共 50 条
  • [1] THE USE OF REAL-WORLD DATA IN DECISION MAKING FOR ONCOLOGY: A REVIEW OF RECENT HEALTH TECHNOLOGY APPRAISALS IN THE UNITED KINGDOM
    Koufopoulou, M.
    Wissinger, E.
    Oladapo, T.
    Stewart, F.
    Depalma, S.
    Devani, D.
    Rangi, N. D.
    Fusco, N.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S262 - S262
  • [2] The use of surrogate endpoints in health technology assessment for oncology drugs
    Lasys, Tomas
    Karinauske, Egle
    Kasciuskeviciute, Skaiste
    Usaite, Akvile
    Stankeviciute, Simona
    Sadauskas, Vladas
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 33 - 33
  • [3] SURROGATE ENDPOINTS USED IN NICE TECHNOLOGY APPRAISALS FOR ONCOLOGY AND NON-ONCOLOGY INDICATIONS, 2022-23
    Heptinstall, A.
    Adkins, E.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S331 - S331
  • [4] A REVIEW OF HEALTH TECHNOLOGY APPRAISALS: CASE STUDIES IN ONCOLOGY
    Shah, Koonal Kirit
    Mestre-Ferrandiz, Jorge
    Towse, Adrian
    Smyth, Emily Nash
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (01) : 101 - 109
  • [5] Endpoints and surrogate endpoints in colorectal cancer: a review of recent developments
    Piedbois, Pascal
    Buyse, Marc
    [J]. CURRENT OPINION IN ONCOLOGY, 2008, 20 (04) : 466 - 471
  • [6] Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines
    Bogdan Grigore
    Oriana Ciani
    Florian Dams
    Carlo Federici
    Saskia de Groot
    Meilin Möllenkamp
    Stefan Rabbe
    Kosta Shatrov
    Antal Zemplenyi
    Rod S. Taylor
    [J]. PharmacoEconomics, 2020, 38 : 1055 - 1070
  • [7] Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines
    Grigore, Bogdan
    Ciani, Oriana
    Dams, Florian
    Federici, Carlo
    de Groot, Saskia
    Moellenkamp, Meilin
    Rabbe, Stefan
    Shatrov, Kosta
    Zemplenyi, Antal
    Taylor, Rod S.
    [J]. PHARMACOECONOMICS, 2020, 38 (10) : 1055 - 1070
  • [8] ADOPTION OF PIECEWISE MODELLING: A REVIEW OF NICE HEALTH TECHNOLOGY APPRAISALS IN ONCOLOGY
    Liu, B. L.
    Griffiths, M.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S356 - S356
  • [9] Use of surrogate outcomes in cost-effectiveness mode's: A review of United Kingdom health technology assessment reports
    Elston, Julian
    Taylor, Rod S.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (01) : 6 - 13
  • [10] Cardioprotection and surrogate/hard endpoints - Lessons from the United Kingdom Prospective Diabetes Study
    Yudkin, JS
    [J]. XXI CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY, 1999, : 633 - 636
12345